Retention and Reserve Samples Clause Samples
The 'Retention and Reserve Samples' clause requires parties to retain samples of materials, products, or goods for a specified period after delivery or production. Typically, this involves keeping a set quantity of the product in controlled conditions to allow for future testing, quality verification, or dispute resolution. By mandating the retention of these samples, the clause ensures that there is tangible evidence available to address potential quality concerns, product recalls, or compliance issues that may arise after the initial transaction.
Retention and Reserve Samples. LONZA shall identify and retain certain reserve samples of all Raw Materials and intermediate production samples generated in the production of Clinical Batches as set forth in the applicable Materials Specifications, the applicable standard operating procedures, the Master Production Record or as otherwise agreed in writing by LONZA and PROTEON.
Retention and Reserve Samples. Lonza shall isolate, identify and, subject to Section 18.3 hereof, retain retention and reserve samples of all raw materials and components and in-process production steps used in the production of Bulk Drug as may be required by written processes and procedures to be agreed upon in writing by Lonza and Trubion from time to time.
Retention and Reserve Samples. CBSB shall identify and retain certain reserve samples of all Raw Materials and intermediate production samples generated in the production of Drug Substance as set forth in the applicable Materials Specifications, the applicable standard operating procedures, the Master Production Record or as otherwise agreed in writing by CBSB and Tercica.
Retention and Reserve Samples. The Parties shall mutually identify and Paragon shall retain (until Client Approval pursuant to Section 5.2) certain reserve samples of all Raw Materials, intermediate manufacture samples, and Product generated in the manufacture of Production Batches as set forth in the applicable Materials Specifications, the applicable standard operating procedures, the Master Manufacturing Record or as otherwise agreed in writing by Paragon and Client as provided in the Quality Agreement. Paragon may retain a reserve sample of the Product from each Batch for a period of time in Paragon’s sole discretion.
Retention and Reserve Samples. FibroGen shall retain (or have retained) certain reserve samples of all Raw Materials and in-process material production samples generated during production of Batches as set forth in the Quality Agreement, the applicable standard operating procedures and Applicable Laws, or as otherwise agreed in a signed writing by FibroGen and Astellas.
Retention and Reserve Samples. STA shall identify and retain certain reserve samples as set forth in the Quality Agreement, the Master Batch Record, the applicable standard operating procedures and Applicable Laws, or as otherwise agreed to in a signed writing by STA and FibroGen.
Retention and Reserve Samples. Catalent shall identify and retain certain reserve samples as set forth in the Quality Agreement, the Master Batch Record, the applicable standard operating procedures and Applicable Laws, or as otherwise agreed to in a signed writing by Catalent and FibroGen.
Retention and Reserve Samples. BIP shall isolate, identify and, subject to Section 19.3(e)(3) hereof, retain retention and reserve samples of all raw materials and in-process production steps used in the production of Bulk Drug Substance, Drug Product and Finished Product for such period as agreed upon by the Parties. BIP shall retain quantities of such retention and reserve samples at least equal to [*] ([*]) times the amounts required to perform full testing of such retention and reserve samples. All retention and reserve samples shall be promptly provided by BIP to Buyer at Buyer's request, provided that BIP may retain one set of such samples for documentation purposes. Shipment of such samples shall be at Buyer's cost and risk.
Retention and Reserve Samples. Genentech shall isolate, identify and, ----------------------------- subject to Section 19.3 hereof, retain retention and reserve samples of all ------------ raw materials and in-process production steps used in the production of Bulk Drug as may be required by standard operating procedures to be agreed upon in writing by Genentech and Immunex from time to time.
Retention and Reserve Samples. Wyeth shall use its Commercially Reasonable Efforts to isolate, identify and, subject to Section 21.9.4 hereof, retain retention and reserve samples of all Raw Materials and in-process production steps used in the production of Product as may be required by standard operating procedures to be agreed upon in writing by Wyeth and Genentech from time to time.